Chengang Zhou

This inventor holds 12 USPTO granted patents and 13 published patent applications and 10 EPO patents. Top assignee: Hoffmann-La Roche Inc.. Active years: 2016-2026.

USPTO Granted Patents = 12 (Patent Applications = 13)

% Patents Active = 58.3

EPO Patents = 10 (Patent Applications = 20)

Average Co-Inventor Count = 8.7

ph-index = 2

Forward Citations = 31(Granted Patents)

Company Filing History:

12 out of 5,020

Hoffmann-La Roche Inc.

patents

Years Active: 2016-2026

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12679824 - Imidazole-pyrazole derivatives (2026-07-14),

2. 12655126 - Imidazole-pyrazole derivatives as antibacterials (2026-06-16),

3. 12617798 - Imidazopyrazne derivatives (2026-05-05),

4. 12595255 - Heteroaryl-substituted imidazole derivatives (2026-04-07),

5. 12421211 - Heterocyclic compounds (2025-09-23),

6. 11858912 - Heterocyclic compounds (2024-01-02),

7. 11390604 - Imidazole-pyrazole derivatives (2022-07-19),

8. 10662203 - Pyrido[2,3-b]indole compounds for the treatment and prophylaxis of bacterial infection (2020-05-26),

9. 9949966 - Dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection (2018-04-24),

10. 9637485 - 6,7-dihydrobenzo[a]quinolizin-2-one derivatives for the treatment and prophylaxis of hepatitis B virus infection (2017-05-02),

11. 9458153 - Dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection (2016-10-04),

12. 9458106 - Phenyl-pyridine/pyrazine amides for the treatment of cancer (2016-10-04),

Title: Chengang Zhou: Inspiring a Legacy of Innovation in the Tech Industry

Introduction:

Chengang Zhou, a visionary inventor based in Shanghai, China, is leaving an indelible mark on the tech industry through his passion for innovation and relentless pursuit of excellence. His work continues to inspire the next generation of inventors and innovators worldwide.

Latest Patents:

Among his impressive portfolio of inventions, Chengang Zhou holds 7 patents. Two of his latest groundbreaking patents include:

1. Heterocyclic compounds: This invention unveils novel heterocyclic compounds with significant pharmaceutical applications, particularly in antibiotic treatments for bacterial infections and associated diseases.

2. Imidazole-pyrazole derivatives: Chengang Zhou's innovative disclosure of new imidazole-pyrazole derivatives showcases his commitment to advancing pharmaceutical compositions for antibiotic therapies.

Career Highlights:

Chengang Zhou's career has been marked by innovation and pioneering research. Notably, he has made significant contributions while working at renowned companies like Roche Inc. (formerly known as Hoffmann-la Roche Inc.). His expertise and groundbreaking inventions have propelled the tech industry forward.

Collaborations:

Throughout his career, Chengang Zhou has collaborated closely with esteemed colleagues such as Song Yang and Xingchun Han. Their collective efforts have led to innovative solutions and advancements in the field of pharmaceuticals and technology.

Conclusion:

In conclusion, Chengang Zhou's remarkable impact on the tech industry through his innovative patents, collaborations, and unwavering commitment to excellence serves as a beacon for aspiring inventors. His legacy will undoubtedly shape the future of technology for generations to come, inspiring a new wave of creativity and progress in the ever-evolving tech landscape.